Search results for "Serenoa"

showing 3 items of 3 documents

Fungal planet description sheets : 1042-1111

2020

Novel species of fungi described in this study include those from various countries as follows: Antarctica, Cladosporium arenosum from marine sediment sand. Argentina, Kosmimatamyces alatophylus (incl. Kosmimatamyces gen. nov.) from soil. Australia, Aspergillus banksianus, Aspergillus kumbius, Aspergillus luteorubrus, Aspergillus malvicolor and Aspergillus nanangensis from soil, Erysiphe medicaginis from leaves of Medicago polymorpha, Hymenotorrendiella communis on leaf litter of Eucalyptus bicostata, Lactifluus albopicri and Lactifluus austropiperatus on soil, Macalpinomyces collinsiae on Eriachne benthamii, Marasmius vagus on soil, Microdochium dawsoniorum from leaves of Sporobolus natale…

BuxusITS nrDNA barcodesEvolution:Zoology and botany: 480 [VDP]new taxaBehavior and SystematicsNew taxaSystematicsBotanyEuphorbia paraliassystematics:Zoologiske og botaniske fag: 480 [VDP]Ecology Evolution Behavior and SystematicsLSUbiologyEcologySettore BIO/02 - Botanica SistematicaITS nrDNA barcodes LSU new taxa systematicsSerenoa repensPlant litterbiology.organism_classificationEucalyptusITS nrDNA barcodes; LSU; New taxa; SystematicsLaboratorium voor PhytopathologieCortinariusLaboratory of PhytopathologyEucalyptus bicostataITS nrDNA barcodes ; LSU ; new taxa ; systematicsEPSCladosporium
researchProduct

Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between…

2014

BACKGROUND Phytotherapy has been used to treat patients with lower urinary tract symptoms (LUTS). We evaluated the efficacy and tolerability of combination therapy between Serenoa Repens (SeR), Lycopene (Ly), and Selenium (Se) + tamsulosin versus single therapies. METHODS PROCOMB trial (ISRCTN78639965) was a randomized double-blinded, double-dummy multicenter study of 225 patients between 55 and 80 years old, PSA ≤ 4 ng/ml, IPSS ≥12, prostate volume ≤60 cc, Qmax ≤15 ml/sec, postvoid residual urine (PVR) <150 ml. Participants were randomized group A (SeR-Se-Ly), group B (tamsulosin 0.4 mg), group C (SeR-Se-Ly + tamsulosin 0.4 mg). The primary endpoints of the study were the reduction of IPSS…

medicine.medical_specialtybiologyCombination therapybusiness.industryUrologyUrologyurologic and male genital diseasesmedicine.diseasebiology.organism_classificationGroup BSurgerylaw.inventionmedicine.anatomical_structureOncologyTolerabilityRandomized controlled triallawLower urinary tract symptomsProstateTamsulosinmedicineSerenoabusinessmedicine.drugThe Prostate
researchProduct

Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between…

2014

serenoa repensMaleProstatic HyperplasiaAntioxidantsSettore MED/24 - UrologiaSeleniumDouble-Blind MethodDrug TherapyLower Urinary Tract SymptomsSerenoa80 and overHumansBPH; LUTS; lycopene; phytotherapy; selenium; serenoa repens; tamsulosin; Aged; Aged 80 and over; Antioxidants; Carotenoids; Double-Blind Method; Drug Therapy Combination; Humans; Italy; Lower Urinary Tract Symptoms; Male; Middle Aged; Phytotherapy; Prostatic Hyperplasia; Quality of Life; Selenium; Serenoa; Sulfonamides; Treatment Outcome; Urodynamics; Urological AgentsAgedSulfonamidesLUTSphytotherapyMiddle AgedlycopeneCarotenoidsBPH LUTS lycopene phytotherapy selenium serenoa repens tamsulosinUrodynamicsTreatment OutcomeItalyBPHtamsulosinCombinationQuality of LifeUrological Agentsserenoa repens; lycopene; selenium; tamsulosin; LUTS; BPH; phytotherapy
researchProduct